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Understanding the interactions between miRNAs and genes they
regulate during the acute phase response is crucial to our under-
standing of inﬂammatory diseases and processes. Inducing the acute
phase response in hepatocytes by stimulating themwith interleukin-6
[1] and then examining global changes in mRNA and miRNA
expression can provide insight into the timing and dynamics of these
interactions. Here we provide additional data for our study, Ref. [2]. In
this data, we identify and validate IL-6-induced changes in gene
expression [3–6] and their functional relationships over time and
between cell types by gene ontology [7,8]. We also provide data
showing the enrichment of miRNA binding motifs in the 3'UTRs of
differentially expressed genes [9], and their predicted gene targets
derived from our RNA-seq data [10].
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).ier Inc. This is an open access article under the CC BY license
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More speciﬁc
subject areaHepG2, human and mouse hepatocyte mRNA and miRNA transcriptomeType of data Tables, graphs, image
How data was
acquiredRNA-seq using Illumina Hi-Seq 2000, qPCR, western blotData format Analyzed
Experimental factors Hepatocytes were either untreated or stimulated with interleukin-6, and mRNA and small RNA-seq
libraries were generated for untreated, 6 h and 24 h post-IL-6 timepoints.
Experimental
featuresSamples were HepG2 cells, human primary hepatocytes derived from healthy liver tissue, and mouse
hepatocytes were derived from healthy mice with a mixed 129 Sv/C57Bl6J genetic background.Data source location Geneva, Switzerland
Data accessibility Data is available with the article1.1. Value of the data This data provides an integrated analysis of miRNA and mRNA expression in a model of the acute
phase response in human and mouse hepatocytes. We investigated mRNA and miRNA expression between cell types after IL-6 stimulation.
 We observed a delayed response in gene expression changes in mouse hepatocytes compared to
HepG2 cells and human hepatocytes. This is also reﬂected in the gene ontology and pathways
analyses. We identiﬁed a subset of differentially expressed miRNAs that regulate the expression of important
acute phase response genes at speciﬁc time points, and in different hepatocyte models, following
induction of the IL-6-mediated acute phase response.
2. Data, experimental design, materials and methods
Figure 1: Top 20 up- and down-regulated genes in HepG2 (A–E), human primary hepatocytes (F–J)
and mouse primary hepatocytes (K–O) between 0–6 h, 0–24 h, 6–24 h, 6 h7 IL-6 and 24 h7 IL-6.
Time zero¼untreated cells. Plotted values are the log2 fold-change of gene expression.
Figure 2: ConsensusPathDB (CPdB) analyses of GO terms and enriched pathways in HepG2 cells.
The p-value cutoff was 0.01 and the minimum input overlap was 2.
Figure 3: CPdB analyses of GO terms and enriched pathways in human primary hepatocytes. The p-
value cutoff was 0.01 and the minimum input overlap was 2.
Figure 4: CPdB analyses of GO terms and enriched pathways in mouse primary hepatocytes. The p-
value cutoff was 0.01 and the minimum input overlap was 2.
Figure 5: Heatmap of mean expression (log2 RPKM) of the 0–24 h intersection genes in all three
cell types (23 genes), with expression data for untreated (UT), 6 h and 24 h post-IL-6 induction – see
Figure 1 in Ref. [2].
Figure 6: Validation of RNA-seq data (RPKM) by qPCR and western blot. Fibrinogen mRNA
expression (FGA, FGB, FGG) was validated using qPCR in human primary hepatocytes (A and B) and
mouse primary hepatocytes (C and D). Gene expression is expressed as a percentage of the IL-6
untreated control (black bars). The time zero data in the IL-6-positive samples is also untreated. Panel
E shows a western blot of secreted ﬁbrinogen protein, reduced to the individual chains (Aα, Bβ, and Ɣ),
in conditioned media from human primary hepatocyte cultures that were either untreated or treated
with IL-6 for 6 h or 24 h. The protein control is puriﬁed ﬁbrinogen preparation, and the loading control
is secreted albumin in the conditioned media.
Table 1: Differentially expressed miRNAs in IL-6-stimulated hepatocytes (heatmap data,
untransformed cpm values – see Figure 4 in Ref. [2]).
Table 2: Signiﬁcant miRNAs binding to over-represented 8nt motif in up- or down-regulated DE
mRNA targets. P-value is the signiﬁcance of the complementarity between the Weeder-calculated
sequence motif and the miRNA seed. Asterisk represents the star-arm of miRNA precursor.
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expressed TargetScan-predicted targets. Entries in bold text are statistically signiﬁcant (Po0.05).
Table 4: Up-regulated DE mRNA targets of down-regulated DE miRNAs in HepG2 cells.
Table 5: Up-regulated DE mRNA targets of down-regulated DE miRNAs in human primary
hepatocytes.
Table 6: Up-regulated DE mRNA targets of down-regulated DE miRNAs in mouse primary
hepatocytes.Appendix A. Supporting information
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.05.023.References
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